Browse > Article
http://dx.doi.org/10.3839/jabc.2008.001

Identification of Genes Differentially Expressed in the MCF-7 Cells Treated with Mitogenic Estrogens  

Cheon, Myeong-Sook (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Yoon, Tae-Sook (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Lee, Do-Yeon (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Choi, Go-Ya (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Lee, A-Yeong (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Choo, Byung-Kil (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Kim, Ho-Kyoung (Department of Herbal Resources Research, Korea Institute of Oriental Medicine)
Publication Information
Journal of Applied Biological Chemistry / v.51, no.1, 2008 , pp. 1-6 More about this Journal
Abstract
Estrogens, a group of steroid compounds functioning as the primary female sex hormone, play an important role in the development and progression of breast cancer. In this study, using a novel annealing control primer-based GeneFishing PCR technology, five differentially expressed genes (DEGs), expressed using 10nM mitogenic estrogens, $17{\beta}$-estradiol (E2) and $16{\alpha}$-hydroxyestrone ($16{\alpha}$-OHE1), were selected from the estrogen receptor (ER)-positive MCF-7 human breast cancer cells. The DEGs, MRPL42, TUBA1B, SSBP1, KNCT2, and RUVBL1, were identified by comparison with the known genes via direct sequencing and sequence homology search in BLAST. Quantitative real-time PCR data showed that two DEGs, tubulin ${\alpha}1b$ and kinetochore associated 2, were greater than 2-fold upregulated by E2 or $16{\alpha}$-OHE1. Both genes could be new biomarkers for the treatment and prognosis of cancers, and further study may provide insights into the molecular mechanisms underlying development and progression of breast cancer.
Keywords
differentially expressed genes$17{\beta}$-estradiol; estrogen receptor-positive MCF-7 human breast cancer cells$16{\alpha}$-hydroxyestrone; kinetochore associated 2; tubulin ${\alpha}1b$;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Rozen S and Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S and Misener S. pp. 365-386, Humana Press. Totowa, NJ
2 Darbre P, Yates J, Curtis S, and King RJ (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res 43, 349-354
3 Ernst M, Schmid C, and Froesch ER (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. Steroid Biochem 33, 907-914   DOI   ScienceOn
4 Fishman J, Schneider J, Hershcope RJ, and Bradlow HL (1984) Increased estrogen-16$\alpha$-hydroxylase activity in women with breast and endometrial cancer. Steroid Biochem 20, 1077-1081   DOI   ScienceOn
5 Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the $2^{{-\Delta}{\Delta}CT}$ method. Methods 25, 402-408   DOI   ScienceOn
6 Martin-Lluesma S, Stucke VM, and Nigg EA (2002) Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297, 2267-2270   DOI   ScienceOn
7 McGuire WL, Horwitz KB, Chamness GC, and Zava DT (1976) A physiological role for estrogen and progesterone in breast cancer. J Steroid Biochem 7, 875-882   DOI   ScienceOn
8 Delmas PD (1997) Hormone replacement therapy in the prevention and treatment of osteoporosis. Osteoporos Int Suppl 1, S3-7
9 Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, and Toi M (2005) Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 24, 4531-4539   DOI   ScienceOn
10 Li L, Yang L, Scudiero DA, Miller SA, Yu ZX, Stukenberg PT, Shoemaker RH, and Kotin RM (2007) Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells. Gene Ther 14, 817-824
11 Sengupta S and Thomas SA (2006) Drug target interaction of tubulin-binding drugs in cancer therapy. Expert Rev Anticancer Ther 6, 1433-1447   DOI   ScienceOn
12 Fishman J and Martucci C (1980) Biological properties of 16$\alpha$-hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin Endocrinol Metab 51, 611-615   DOI
13 Banerjee A (2002) Increased levels of tyrosinated $\alpha$-, $\beta$(III)-, and $\beta$(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun 293, 598-601   DOI   ScienceOn
14 Hayama S, Daigo Y, Kato T, Ishikawa N, Yamabuki T, Miyamoto M, Ito T, Tsuchiya E, Kondo S, and Nakamura Y (2006) Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res 66, 10339-10348   DOI   ScienceOn
15 Clemons M and Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344, 276-285   DOI   ScienceOn
16 Hwang KC, Cui XS, Park SP, Shin MR, Park SY, Kim EY, and Kim NH (2004) Identification of differentially regulated genes in bovine blastocysts using an annealing control primer system. Mol Reprod Dev 69, 43-51   DOI   ScienceOn
17 Kim SH, Lee SU, Kim MH, Kim BT, and Min YK (2005) Mitogenic estrogen metabolites alter the expression of 17$\beta$-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol Cells 20, 378-384
18 Swaneck GE and Fishman J (1988) Covalent binding of the endogenous estrogen 16$\alpha$-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 85, 7831-7835
19 Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, and Kao GD (2004) Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol Cancer Ther 3, 661-669
20 Lewis JS, Thomas TJ, Klinge CM, Gallo MA, and Thomas T (2001) Regulation of cell cycle and cyclins by 16$\alpha$- hydroxyestrone in MCF-7 breast cancer cells. J Mol Endocrinol 27, 293-307   DOI   ScienceOn
21 Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, and Wenger N; HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 288, 49-57   DOI   ScienceOn
22 Gupta M, McDougal A, and Safe S (1998) Estrogenic and antiestrogenic activities of 16$\alpha$- and 2-hydroxy metabolites of 17$\beta$-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 67, 413-419   DOI   ScienceOn
23 Kim YJ, Kwak CI, Gu YY, Hwang IT, and Chun JY (2004) Annealing control primer system for identification of differentially expressed genes on agarose gels. BioTechniques 36, 424-426, 428, 430 passim
24 Ryu JY, Lee BM, Kacew S, and Kim HS (2007) Identification of differentially expressed genes in the testis of Sprague-Dawley rats treated with di(n-butyl) phthalate. Toxicology 234, 103-112   DOI   ScienceOn
25 DeLuca JG, Gall WE, Ciferri C, Cimini D, Musacchio A, and Salmon ED (2006) Kinetochore microtubule dynamics and attachment stability are regulated by Hec1. Cell 127, 969-982   DOI   ScienceOn
26 Schneider J. Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, and Fishman J (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79, 3047-3051